[Simultaneous surgery for concomitant lung cancer and diffuse coronary atherosclerosis].
V A Porkhanov1,2, S A Belash1,2, I S Polyakov1
1Research Institute - Ochapovskiy Regional Clinical Hospital No.1, Krasnodar, Russia.
Khirurgiia
|March 12, 2021
Summary
Simultaneous surgery for lung cancer and coronary artery disease is safe. This combined approach showed no in-hospital deaths and manageable complications in patients needing both lung resection and coronary artery bypass grafting.
Area of Science:
- Cardiothoracic Surgery
- Oncology
- Cardiovascular Disease
Background:
- Concomitant lung cancer and coronary artery disease present a complex surgical challenge.
- Optimal management strategies for patients requiring both lung resection and coronary artery bypass grafting (CABG) are critical.
Purpose of the Study:
- To evaluate the early clinical outcomes of performing simultaneous lung resection and coronary artery reconstruction in patients with both conditions.
Main Methods:
- Retrospective review of 37 patients undergoing combined CABG with endarterectomy or coronary artery reconstruction and lung resection.
- Procedures performed via median sternotomy, with myocardial revascularization preceding on-pump lung resection.
- Commonly involved right upper lobe lobectomy and lymph node dissection.
Main Results:
- No in-hospital mortality observed.
- Perioperative myocardial infarction occurred in 5.4% of patients.
- Postoperative complications included atrial fibrillation (16.6%) and pneumonia (5.4%); mean hospital stay was 14.4 days.
Conclusions:
- Simultaneous lung resection and coronary artery reconstruction is a safe and effective surgical option for selected patients.
- A systematic approach to patient selection, evaluation, and surgical treatment is essential for successful outcomes.
- Larger randomized trials are needed to further confirm these findings.
